Institutional Ownership Iovance Biotherapeutics, Inc. (IOVA)
This table provides information about the institutional ownership of Iovance Biotherapeutics, Inc. (IOVA). We have compiled data on the 327 institutions that hold shares in the stock, with a total of 247 Million shares, which have been reported (via 13F filing form) to have a value of $577 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
27,777,778
shares
|
$65 Million
0.0% of portfolio
|
Q1 2025
Added 0.88%
|
|
|
Mhr Fund Management LLC
New York, NY |
May 15, 2025 Q1 2025 |
24,417,103
shares
|
$57.1 Million
12.15% of portfolio
|
Q4 2024
Added 1.75%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
21,225,119
shares
|
$49.7 Million
0.0% of portfolio
|
Q2 2024
Added 6.5%
|
|
|
Perceptive Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
12,711,788
shares
|
$29.7 Million
1.77% of portfolio
|
Q1 2025
Reduced 42.51%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
11,041,322
shares
|
$25.8 Million
0.0% of portfolio
|
Q1 2025
Reduced 9.86%
|
|
|
Long Focus Capital Management, LLC
San Juan, PR |
May 15, 2025 Q1 2025 |
9,250,055
shares
|
$21.6 Million
1.07% of portfolio
|
Q1 2025
Added 80.24%
|
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
May 15, 2025 Q1 2025 |
9,216,040
shares
|
$21.6 Million
0.58% of portfolio
|
Q1 2025
Added 2.5%
|
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
May 15, 2025 Q1 2025 |
7,785,000
shares
|
$18.2 Million
2.15% of portfolio
|
Q1 2025
Added 18.67%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
5,968,298
shares
|
$14 Million
0.0% of portfolio
|
Q1 2025
Added 1.65%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
May 19, 2025 Q1 2025 |
5,777,344
shares
|
$13.5 Million
0.01% of portfolio
|
Q1 2025
Added 202.84%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
5,571,902
shares
|
$13 Million
0.0% of portfolio
|
Q1 2025
Added 35.57%
|
|
|
Invenomic Capital Management LP
Boston, MA |
May 15, 2025 Q1 2025 |
5,489,799
shares
|
$12.8 Million
0.92% of portfolio
|
Q1 2025
New holding
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
5,175,080
shares
|
$12.1 Million
0.04% of portfolio
|
Q2 2023
Added 436.67%
|
|
|
Macquarie Group LTD
Australia, C3 |
May 15, 2025 Q1 2025 |
4,791,235
shares
|
$11.2 Million
0.02% of portfolio
|
Q1 2025
Added 0.85%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Apr 28, 2025 Q1 2025 |
4,694,122
shares
|
$11 Million
0.01% of portfolio
|
Q1 2025
Added 28.72%
|
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
May 14, 2025 Q1 2025 |
4,407,713
shares
|
$10.3 Million
0.03% of portfolio
|
Q1 2025
Reduced 2.96%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
4,018,374
shares
|
$9.4 Million
0.0% of portfolio
|
Q1 2025
Added 1.48%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
3,511,400
shares
|
$8.22 Million
0.02% of portfolio
|
Q1 2025
New holding
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
3,506,108
shares
|
$8.2 Million
0.0% of portfolio
|
Q1 2025
Added 44.27%
|
|
|
Palo Alto Investors LP
Palo Alto, CA |
May 15, 2025 Q1 2025 |
3,211,314
shares
|
$7.51 Million
2.14% of portfolio
|
Q1 2025
Added 5.58%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
3,017,185
shares
|
$7.06 Million
0.0% of portfolio
|
Q1 2025
Added 306.95%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
May 15, 2025 Q1 2025 |
2,708,582
shares
|
$6.34 Million
1.67% of portfolio
|
Q1 2025
Added 1.3%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
2,496,749
shares
|
$5.84 Million
0.0% of portfolio
|
Q1 2025
Reduced 7.68%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
2,404,080
shares
|
$5.63 Million
0.0% of portfolio
|
Q1 2025
Reduced 8.52%
|
|
|
683 Capital Management, LLC
New York, NY |
May 15, 2025 Q1 2025 |
2,400,000
shares
|
$5.62 Million
0.64% of portfolio
|
Q1 2025
Added 69.49%
|